Genetics of anthracycline-associated cardiotoxicity

HIGHLIGHTS

• who: Usman A. Tahir and Aarti Asnani from the CardioVascular Institute, Beth Israel Deaconess Medical Center, Boston, MA, United States University of California, Los Angeles have published the research work: Genetics of Anthracycline-Associated Cardiotoxicity, in the Journal: (JOURNAL)
• what: Anthracycline-induced cardiomyopathy is a complex adverse drug reaction that is associated with morbidity, mortality, and increased social and economic burden for patients, their families, and the healthcare system.
• future: POTENTIAL USES OF GENETIC TESTING IN PATIENTS WHO DEVELOP ANTHRACYCLINE ASSOCIATED CARDIOTOXICITY FUTURE DIRECTIONS More studies are needed to identify high risk genetic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.